Utah Medical Products, Inc.

Historical 13F Holders

Symbol
UTMD
CUSIP
917488108
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 917488108 since 12/18/2024, largest first.

Filer % of Class Filed
Dimensional Fund Advisors LP 13G/A 6.1% 7/15/2025
Event 6/30/2025
Renaissance Technologies LLC 13G/A
5.5% 8/13/2026
Event 6/30/2026
BlackRock, Inc. 13G 5.3% 7/17/2025
Event 6/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Brandes Investment Partners, LP 13G/A
14.8%
Checked 5% or less
11/16/2026
Event 9/30/2026
FMR LLC 13G/A
2.7% 1/8/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 129 2.33 M $172M
2026 Q2 116 2.32 M $160M
2026 Q1 120 2.27 M $140M
2025 Q4 117 2.10 M $118M
2025 Q3 117 2.18 M $137M
2025 Q2 113 2.16 M $123M
2025 Q1 111 2.24 M $126M
2024 Q4 113 2.31 M $142M
2024 Q3 113 2.41 M $161M
2024 Q2 102 2.42 M $162M
2024 Q1 101 2.49 M $177M
2023 Q4 90 2.52 M $212M
2023 Q3 93 2.57 M $221M
2023 Q2 91 2.55 M $237M
2023 Q1 88 2.54 M $241M
2022 Q4 83 2.55 M $256M
2022 Q3 79 2.54 M $216M
2022 Q2 76 2.56 M $220M
2022 Q1 87 2.57 M $231M
2021 Q4 80 2.60 M $260M
2021 Q3 73 2.60 M $242M
2021 Q2 69 2.60 M $221M
2021 Q1 80 2.63 M $228M
2020 Q4 78 2.62 M $221M
2020 Q3 86 2.65 M $212M
2020 Q2 94 2.69 M $238M
2020 Q1 91 2.63 M $247M
2019 Q4 97 2.77 M $299M
2019 Q3 98 2.85 M $273M
2019 Q2 99 2.76 M $266M
2019 Q1 94 2.72 M $242M
2018 Q4 89 2.73 M $229M
2018 Q3 91 2.80 M $263M
2018 Q2 92 2.60 M $286M
2018 Q1 81 2.59 M $256M
2017 Q4 78 2.50 M $203M
2017 Q3 74 2.48 M $182M
2017 Q2 76 2.48 M $179M
2017 Q1 76 2.42 M $151M
2016 Q4 75 2.48 M $180M
2016 Q3 79 2.50 M $150M
2016 Q2 76 2.52 M $159M
2016 Q1 68 2.56 M $160M
2015 Q4 64 2.51 M $147M
2015 Q3 59 2.47 M $133M
2015 Q2 63 2.47 M $147M
2015 Q1 62 2.41 M $146M
2014 Q4 60 2.47 M $149M
2014 Q3 62 2.21 M $108M
2014 Q2 63 2.43 M $125M
2014 Q1 59 2.40 M $139M